Skip to main content

Protein Design Labs to Use Cyntellect s LEAP Platform

NEW YORK, Oct. 27 (GenomeWeb News) - Protein Design Labs will use Cyntellect's Cell Xpress Laser Enabled Analysis and Processing service, the companies said yesterday.

 

Cyntellect's LEAP platform, which is part of the company's Cell Xpress service, was designed to enable researchers to image and measure protein secretions in situ in high-throughput on individual cells.

 

Financial terms of the deal were not disclosed.

 

The news comes one month after Cyntellect received around $1.5 million in a Phase II Small Business Innovative Research grant to continue developing RNA interference applications on the LEAP platform.

 

Specifically, the money will help the privately held company develop its LEAP-enabled LaserFect technology for low-toxicity delivery of siRNA into cells "that are typically refractory to standard transfection techniques."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.